Our top pick for
CHP Merger Corp is a shell companies business based in the US. CHP Merger shares (CHPM) are listed on the NASDAQ and all prices are listed in US Dollars.
|Latest market close||$10.04|
|52-week range||$9.71 - $10.78|
|50-day moving average||$10.01|
|200-day moving average||$9.98|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.69|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||0.18%|
|1 month (2021-09-21)||0.28%|
|3 months (2021-07-21)||0.60%|
|6 months (2021-04-21)||0.48%|
|1 year (2020-10-21)||-0.02%|
|2 years (2019-10-17)||N/A|
|3 years (2018-10-17)||N/A|
|5 years (2016-10-17)||N/A|
Valuing CHP Merger stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CHP Merger's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CHP Merger's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, CHP Merger shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Gross profit TTM||$0|
|Return on assets TTM||-0.14%|
|Return on equity TTM||19.2%|
|Market capitalisation||$375.8 million|
TTM: trailing 12 months
There are currently 360,558 CHP Merger shares held short by investors – that's known as CHP Merger's "short interest". This figure is 6.4% up from 338,741 last month.
There are a few different ways that this level of interest in shorting CHP Merger shares can be evaluated.
CHP Merger's "short interest ratio" (SIR) is the quantity of CHP Merger shares currently shorted divided by the average quantity of CHP Merger shares traded daily (recently around 69740.425531915). CHP Merger's SIR currently stands at 5.17. In other words for every 100,000 CHP Merger shares traded daily on the market, roughly 5170 shares are currently held short.
However CHP Merger's short interest can also be evaluated against the total number of CHP Merger shares, or, against the total number of tradable CHP Merger shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CHP Merger's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 CHP Merger shares in existence, roughly 10 shares are currently held short) or 0.0143% of the tradable shares (for every 100,000 tradable CHP Merger shares, roughly 14 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against CHP Merger.
Find out more about how you can short CHP Merger stock.
We're not expecting CHP Merger to pay a dividend over the next 12 months.
CHP Merger Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses with a focus on the healthcare or healthcare related industries in the United States. The company was incorporated in 2019 and is based in Summit, New Jersey. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.